USPTO serial 99235309
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: 18 Jul 2026
The USPTO has rejected your current specimens and requires additional documentation to prove that your goods are in actual commercial use. Additionally, a formal disclaimer for the word 'RUGGED' is required as it is considered descriptive of your goods.
Larry D Veh
DES MOINES, WA, US
| Class | Description | Status | First use |
|---|---|---|---|
| 006 | Ferrocerium rods | ACTIVE | Feb 15, 2021 |
| 009 | Survival blankets to prevent injury due to hypothermia; Signal mirrors; Signal whistles; Magnetic compasses | ACTIVE | Feb 15, 2021 |
| 010 | Medical scissors | ACTIVE | Feb 15, 2021 |
| Date | Code | Event |
|---|---|---|
| Jun 28, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Jun 28, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Apr 18, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Apr 18, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Apr 18, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Apr 6, 2026 | NREV | NOTICE OF REVIVAL - E-MAILED |
| Apr 6, 2026 | PETG | PETITION TO REVIVE-GRANTED |
| Mar 11, 2026 | PROA | TEAS PETITION TO REVIVE RECEIVED |
| Feb 18, 2026 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Feb 18, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Nov 4, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Nov 4, 2025 | GNRT | NON-FINAL ACTION E-MAILED |
| Nov 4, 2025 | CNRT | NON-FINAL ACTION WRITTEN |
| Nov 4, 2025 | DOCK | ASSIGNED TO EXAMINER |
| Oct 22, 2025 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Oct 22, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jun 16, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Jun 16, 2025 | NWAP | NEW APPLICATION ENTERED |